Ethyl dirazepate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ethyl dirazepate
Ethyl dirazepate.svg
Systematic (IUPAC) name
ethyl 7-chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
Clinical data
Legal status
?
Identifiers
CAS number 23980-14-5 YesY
ATC code ?
PubChem CID 208941
UNII 74FAA305EW N
ChEMBL CHEMBL2106231 N
Chemical data
Formula C18H14Cl2N2O3 
Mol. mass 377.221
 N (what is this?)  (verify)

Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[2][3][4]

See also[edit]

References[edit]

  1. ^ ZA Patent 6804601
  2. ^ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009. 
  3. ^ "Drugs of the Future". Thomson Reuters 6 (11). November 1981. 
  4. ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities (eur-lex.europa.eu). 23 October 2001. Retrieved 7 December 2009.